tiprankstipranks
CERo Therapeutics Holdings (CERO)
NASDAQ:CERO
US Market

CERo Therapeutics Holdings (CERO) Financial Statements

68 Followers

CERo Therapeutics Holdings Financial Overview

CERo Therapeutics Holdings's market cap is currently ―. The company's EPS TTM is $-0.379; its P/E ratio is -2.99; CERo Therapeutics Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -305.75K$ -308.28K$ -1.39M$ -434.31K$ -1.29M
EBITDA$ -305.75K$ -308.28K$ -1.39M$ -434.31K$ -1.29M
Net Income Common Stockholders$ -282.76K$ -334.03K$ -1.44M$ -481.71K$ -262.68K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 96.87K$ 119.01K$ 105.23K$ 178.09K$ 475.87K
Total Assets$ 8.56M$ 8.47M$ 14.11M$ 14.43M$ 42.37M
Total Debt$ 0.00$ 1.40M$ 1.18M$ 650.00K$ 650.00K
Net Debt$ -96.87K$ 1.28M$ 1.07M$ 471.91K$ 174.13K
Total Liabilities$ 14.32M$ 13.95M$ 13.56M$ 12.44M$ 39.90M
Stockholders Equity$ -14.20M$ -13.77M$ -13.29M$ -11.58M$ 2.47M
Cash Flow-
Free Cash Flow$ -186.61K$ -256.12K$ -883.10K$ -197.78K$ -373.10K
Operating Cash Flow$ -186.61K$ -256.12K$ -883.10K$ -197.78K$ -373.10K
Investing Cash Flow$ -13.82M$ 5.69M$ 285.24K$ -100.00K$ 180.71M
Financing Cash Flow$ -27.68M$ -5.42M$ 525.00K--
Currency in USD

CERo Therapeutics Holdings Earnings and Revenue History

CERo Therapeutics Holdings Debt to Assets

CERo Therapeutics Holdings Cash Flow

CERo Therapeutics Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis